CD34+selected haematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failure.

MLA

Milone, G., et al. “CD34+selected Haematopoietic Stem Cell (HSC) Not Preceded by Any Immunosuppressive Therapy as Effective Treatment for Graft Failure.” Bone Marrow Transplantation, vol. 35, no. 5, Mar. 2005, pp. 521–22. EBSCOhost, https://doi.org/10.1038/sj.bmt.1704805.

APA

Milone, G., Tornello, A., Leotta, S., Poidomani, M., Mercurio, S., Farsaci, B., Consoli, C., Murgano, P., & Giustolisi, R. (2005). CD34+selected haematopoietic stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failure. Bone Marrow Transplantation, 35(5), 521–522. https://doi.org/10.1038/sj.bmt.1704805

Chicago

Milone, G., A. Tornello, S. Leotta, M. Poidomani, S. Mercurio, B. Farsaci, C. Consoli, P. Murgano, and R. Giustolisi. 2005. “CD34+selected Haematopoietic Stem Cell (HSC) Not Preceded by Any Immunosuppressive Therapy as Effective Treatment for Graft Failure.” Bone Marrow Transplantation 35 (5): 521–22. doi:10.1038/sj.bmt.1704805.